Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Stonegate Updates Coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM) 2025 Q3

October 30, 2025 at 16:43 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Dallas, Texas--(Newsfile Corp. - October 30, 2025) - NCS Multistage Holdings, Inc. (NASDAQ: NCSM): Stonegate Capital Partners updates their coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM). In 3Q25, NCSM reported total revenues of $46.5M, a 6.0% year-over-year increase, outperforming broader industry activity levels. Growth reflected higher U.S. and international product sales primarily with fracturing systems (including the North Sea) and wellbore construction in the Middle East. This was partially offset by softer Canadian product sales on lower rig counts. International revenue increased ~38.0% y/y while U.S. revenue grew by ~36.0% during the same period as tracer diagnostics ramped (including ~$2M from ResMetrics). Canada grew 32% sequentially as spring break-up effects eased. Adjusted Gross margins came in at 41.7%, down slightly from 42.1% in 3Q24. Going forward, we continue to expect modest revenue and margin growth through the remainer of FY25, supported by resilience in core product lines and contributions from the recent ResMetrics acquisition.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

Third quarter revenue increased 6% y/y to $46.5M, supported by stronger U.S. and international activity (fracturing systems and wellbore construction), partially offset by softer Canada.
As of 3Q25, Adj. EBITDA was $7.0M; diluted EPS was $1.37.
ResMetrics contributed ~$2M to U.S. tracer diagnostics in 3Q25; integration is ahead of plan.

Click image above to view full announcement.

About Stonegate

Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies.

Contacts:

Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/272636

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article